Condensed pyridazine derivatives, their production and use

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S236000

Reexamination Certificate

active

06627630

ABSTRACT:

This application is the National Stage of International Application No. PCT/JP99/05786, filed on Oct. 20, 1999.
TECHNICAL FIELD
The present invention relates to condensed pyridazine derivatives exhibiting an excellent anti-allergic, anti-histaminic, anti-inflammatory or eosinophil chemotaxis-inhibiting activity, or other activities, and useful as an agent for treating or preventing atopic dermatitis, allergic rhinitis, bronchial asthma, allergic conjunctivitis, chronic urticaria, etc., their pro-drugs, methods for producing them and use.
BACKGROUND ART
Many condensed pyridazine derivatives are currently synthesized as drugs for a variety of diseases. For example, U.S. Pat. No. 3,915,968 discloses a compound represented by the formula:
wherein R and R
3
independently represent a hydrogen atom or a lower alkyl group (at least one of R and R
3
is a lower alkyl group); R
1
and R
2
represent a heterocyclic group selected from the group consisting of pyrrolidine, piperidine, piperazine and morpholine taken together with the adjacent nitrogen atom; or a salt thereof. U.S. Pat. No. 4,136,182 is closes that a compound represented by the formula:
wherein R represents a hydrogen atom, a phenyl group or a lower alkylcarbonylamino group; R
1
represents morpholino or piperidino; R
2
represents a hydrogen atom or a lower alkyl group (at least one of R and R
2
is a group other than a hydrogen atom; when R is a phenyl group, R
1
is morpholino and R
2
is a lower alkyl group); or a salt thereof, is useful as a bronchodilator for mitigating bronchial spasms.
Also, Japanese Patent Unexamined Publication No. 279447/1995 discloses that a compound represented by the formula:
wherein R
1
represents a hydrogen atom, a lower alkyl group that may be substituted, or a halogen atom; R
2
and R
3
independently represent a hydrogen atom or a lower alkyl group which may be substituted, or may form a 5- to 7-membered ring with the adjacent —C═C—; X represents an oxygen atom or S(O)
p
(p represents an integer of 0 to 2); Y represents a group represented by the formula:
(R
4
and R
5
independently represent a hydrogen atom or a lower alkyl group which may be substituted) or a divalent group derived from a 3- to 7-membered homocycle or heterocycle which may be substituted; R
6
and R
7
independently represent a hydrogen atom, a lower alkyl group which may be substituted, a cycloalkyl group which may be substituted, or an aryl group that may be substituted, or may form a nitrogen-containing heterocyclic group which may be substituted, with the adjacent nitrogen atom; m represents an integer from 0 to 4, and n represents an integer from 0 to 4; or a salt thereof; and, as an example synthetic product, a compound of the formula:
exhibits anti-asthmatic, anti-PAF, anti-inflammatory and anti-allergic activities.
Furthermore, Japanese Patent Unexamined Publication No. 279446/1995 describes a compound represented by the formula:
wherein R
1
represents a hydrogen atom, a lower alkyl group which may be substituted, or a halogen atom; R
2
and R
3
independently represent a hydrogen atom or a lower alkyl group which may be substituted (provided that either of R
2
and R
3
is a hydrogen atom, the other represents a lower alkyl group which may be substituted), or may form a 5- to 7-membered ring taken together with the adjacent —C═C—; X represents an oxygen atom or S(O)
p
(p represents an integer of 0 to 2): Y represents a group represented by the formula:
(R
4
and R
5
independently represent a hydrogen atom or a lower alkyl group which may be substituted) or a divalent group derived from a 3- to 7-membered homocycle or heterocycle which may be substituted; R
6
and R
7
independently represent a hydrogen atom, a lower alkyl group which may be substituted, a cycloalkyl group which may be substituted, or an aryl group which may be substituted, or may form a nitrogen-containing heterocyclic group which may be substituted, taken together with the adjacent nitrogen atom; m represents an integer from 0 to 4, and n represents an integer from 0 to 4; or a salt thereof; and discloses that these compounds possess anti-allergic, anti-inflammatory and anti-PAF (platelet activating factor) activities to suppress bronchial spasms and bronchial contraction, therefore could be utilized as effective anti-asthmatic agents.
On the other hand, as compounds exhibiting anti-allergic or anti-histaminic activities, there may be mentioned, for example, terfenadine (The Merck Index, 12th edition, 9307) and ebastine (The Merck Index, 12th edition, 3534), which are already in clinical use.
And, EP128536 discloses anti-bacterial compounds represented by the formula:
and so on, and U.S. Pat. No. 4,499,088 discloses anti-bacterial compounds represented by the formula:
and so on. However, they never disclose about anti-allergic action, anti-histaminic action, anti-inflammatory action and so on.
There is demand for the development of novel compounds more satisfactory than conventional anti-allergic agents, anti-histaminic agents, anti-inflammatory agents in terms of action efficacy, sustained action, safety etc., their production and novel pharmaceutical composition.
DISCLOSURE OF INVENTION
Through various extensive investigations, the present inventors found that condensed pyridazine compounds represented by the formula:
wherein Ar
1
and Ar
2
are independently an aromatic group which may be substituted, and Ar
1
and Ar
2
may form a condensed cyclic group with an adjacent carbon atom; ring B is a nitrogen-containing heterocycle may be substituted; X and Y are the same or different and are independently a bond, an oxygen atom, S(O)
p
(p is an integer of 0 to 2), NR
4
wherein R
4
is a hydrogen atom or a lower alkyl group, or a divalent linear lower hydrocarbon group which may contain 1 to 3 hetero atoms and the bivalent linear lower hydrocarbon group may be substituted; A is a nitrogen atom or CR
7
(R
7
is a hydrogen atom, a halogen atom, a hydrocarbon group optionally having a substituent, an acyl group or a hydroxy group optionally having a substituent; R
1
, R
2
and R
3
are the same or different and are independently a hydrogen atom, a halogen atom, a hydrocarbon group optionally having a substituent, an acyl group or a hydroxy group which may be substituted; R
8
is a hydrogen atom, a hydroxy group which may be substituted by lower alkyl or a carboxyl group; provided that the nitrogen-containing heterocycle represented by ring B is not a heterocycle represented by the formula:
wherein n is 0 or 1, or a salt thereof, owing to their unique chemical structure characterized by the presence of substitutional piperidine or piperazine via a spacer from the 6-position of the [1,2,4]triazolo[1,5-b]pyridazine or imidazo[1,2-b]pyridazine skeleton, exhibits unexpectedly excellent activities for preventing or treating allergic skin diseases such as contact dermatitis, pruritus and so on.
And, the present inventors found that condensed pyridazine derivatives represented by the formula:
wherein Ar
1′
and Ar
2′
are independently an aromatic group optionally having a substituent, and Ar
1′
and Ar
2′
may form a condensed cyclic group with an adjacent carbon atom; ring B′ is a nitrogen-containing heterocycle optionally having a substituent; X and Y are the same or different and are independently a bond, an oxygen atom, S(O)p (p is an integer of 0 to 2), NR
4
wherein R
4
is a hydrogen atom or a lower alkyl group, or a bivalent linear lower hydrocarbon group which may contain 1 to 3 hetero atoms and the bivalent linear lower hydrocarbon group may be substituted; A is a nitrogen atom or CR
7
wherein R
7
is a hydrogen atom, a halogen atom, a hydrocarbon optionally having a substituent, an acyl group or a hydroxy group optionally having a substituent; R
1
is a hydrocarbon group substituted with an optionally esterified carboxyl group, R
2
and R
3
are the same or different and are independently a hydrogen atom, a halogen atom, a hydrocarbon group optionally havin

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Condensed pyridazine derivatives, their production and use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Condensed pyridazine derivatives, their production and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Condensed pyridazine derivatives, their production and use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3035428

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.